Abstract
Mathematical modeling plays an important and increasing role in drug development. The objective of this chapter is to present the concept of pharmacokinetic (PK) and pharmacodynamic (PD) modeling applied in the pharmaceutical industry. We will introduce typically PK and PD models and present the underlying pharmacological and biological interpretation. It turns out that any PKPD model is a nonautonomous dynamical system driven by the drug concentration. We state a theoretical result describing the general relationship between two widely used models, namely, transit compartments and lifespan models. Further, we develop a PKPD model for tumor growth and anticancer effects based on the present model figures and apply the model to measured data.
Keywords
- Lifespan models
- Mathematical modeling
- Pharmacodynamics
- Pharmacokinetics
- Transit compartments
- Tumor growth
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptions

References
J.S. Barrett, O. Della Casa Alberighi, S. Läer, B. Meibohm, Physiologically based pharmacokinetic (PBPK) modeling in children. Clin. Pharmacol. Ther. 92, 40–49 (2012)
P.L. Bonate, Pharmacokinetic-Pharmacodynamic Modeling and Simulation (Springer, London, 2006)
P.L. Bonate, D.R. Howard, Pharmacokinetics in Drug Development: Advances and Applications, vol. 3 (Springer, Berlin, 2011)
M.E. Burton, L.M. Shaw, J.J. Schentag, W.E. Evans, Applied Pharmacokinetics & Pharmacodynamics: Principles of Therapeutic Drug Monitoring (Lippincott Williams & Wilkins, Philadelphia, 2006)
E.A. Coddington, N. Levinson, Theory of Ordinary Differential Equations (McGraw-Hill, New York, 1955)
M. Danhof, J. de Jongh, E.C.M. De Lange, O. Della Pasqua, B.A. Ploeger, R.A. Voskuyl, Mechanism-based pharmacokinetic-pharmacodynamic modeling: Biophase distribution, receptor theory, and dynamical systems analysis. Annu. Rev. Pharmacol. Toxicol. 47, 357–400 (2007)
M. Danhof, E.C.M. de Lange, O.E. Della Pasqua, B.A. Ploeger, R.A. Voskuyl, Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. Trends Pharmacol. Sci. 29, 186–191 (2008)
N.L. Dayneka, V. Garg, W.J. Jusko, Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21, 457–478 (1993)
J.A. DiMasi, R.W. Hansen, H.G. Grabowski, The price of innovation: New estimates of drug development costs. J. Health Econ. 22, 151–185 (2003)
F.H. Dost, Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, Leipzig, 1953)
F.H. Dost, Grundlagen der Pharmakokinetik (Georg Thieme, Stuttgart, 1968)
J.C. Earp, D.C. DuBois, D.S. Molano, N.A. Pyszczynski, C.E. Keller, R.R. Almon, W.J. Jusko, Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: Mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats. J. Pharmacol. Exp. Ther. 326, 532–545 (2008)
N. Frances, L. Claret, R. Bruno, A. Iliadis, Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer. Cancer Chemother. Pharmacol. 68, 1413–1419 (2011)
J. Gabrielsson, D. Weiner, Pharmacokinetic and pharmacodynamic data analysis: Concepts and applications (Swedish Pharmaceutical Press, Stockholm, 2006)
M. Gibaldi, D. Perrier, Pharmacokinetics Second Edition Revised and Expanded (Marcel Dekker, New York, 1982)
J.V.S. Gobburu, P.J. Marroum, Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making. Clin. Pharmacokinet. 40, 883–892 (2001)
K. Goteti, C.E. Garner, L. Utley, J. Dai, S. Ashwell, D.T. Moustakas, M. Gönen, G. Schwartz, S.E. Kern, S. Zabludoff, P.J. Brassil, Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents. Cancer Chemother. Pharmacol. 66, 245–254 (2010)
S.A. Hill, Pharmacokinetics of drug infusions. Continuing Educ. Anaesth. Crit. Care Pain 4, 76–80 (2004)
H.M. Jones, I.B. Gardner, K.J. Watson, Modelling and PBPK simulation in drug discovery. Astron. Astrophys. Suppl. 11, 155–166 (2009)
G. Koch, Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis. KOPS (Das Institutional Repository der Universität Konstanz, 2012). http://nbn-resolving.de/urn:nbn:de:bsz:352-194726
G. Koch, J. Schropp, General relationship between transit compartments and lifespan models. J. Pharmacokinet. Pharmacodyn. 39, 343–355 (2012)
G. Koch, A. Walz, G. Lahu, J. Schropp, Modeling of tumor growth and anticancer effects of combination therapy. J. Pharmacokinet. Pharmacodyn. 36, 179–197 (2009)
I. Kola, J. Landis, Can the pharmaceutical industry reduce the attrition rates? Nat. Rev. Drug Discov. 3, 711–715 (2004)
W. Krzyzanski, Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models. J. Pharmacokinet. Pharmacodyn. 38, 179–204 (2011)
W. Krzyzanski, J.J. Perez Ruixo, Lifespan based indirect response models. J. Pharmacokinet. Pharmacodyn. 39, 109–123 (2012)
W. Krzyzanski, R. Ramakrishnan, W.J. Jusko, Basic pharmacodynamic models for agents that alter production of natural cells. J. Pharmacokinet. Biopharm. 27, 467–489 (1999)
W. Krzyzanski, S. Woo, W.J. Jusko, Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans. J. Pharmacokinet. Pharmacodyn. 33, 125–166 (2006)
Y. Kwon, Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists (Springer, New York, 2001)
A.K. Laird, Dynamics of tumor growth. Br. J. Cancer 18, 490–502 (1964)
E.D. Lobo, J.P. Balthasar, Pharmacodynamic modeling of chemotherapeutic effects: Application of a transit compartment model to characterize methotrexate effects in vitro. AAPS PharmSci. 4, 212–222 (2002)
P. Macheras, A. Iliadis, in Modeling in Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics. Interdisciplinary Applied Mathematics, vol. 30 (Springer, Berlin, 2006)
D.E. Mager, E. Wyska, W.J. Jusko, Diversity of mechanism-based pharmacodynamic models. Drug Metab. Dispos. 31, 510–519 (2003)
J. Mordenti, S.A. Chen, J.A. Moore, B.L. Ferraiolo, J.D. Green, Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm. Res. 8, 1351–1359 (1991)
B.A. Ploeger, P.H. van der Graaf, M. Danhof, Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling. Drug Metab. Pharmacokinet. 24, 3–15 (2009)
R.M. Savic, D.M. Jonker, T. Kerbusch, M.O. Karlsson, Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J. Pharmacokinet. Pharmacodyn. 34, 711–726 (2007)
L.B. Sheiner, D.R. Stanski, S. Vozeh, R.D. Miller, J. Ham, Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 25, 358–371 (1979)
M. Simeoni, P. Magni, C. Cammia, G. De Nicolao, V. Croci, E. Pesenti, M. Germani, I. Poggesi, M. Rocchetti, Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res. 64, 1094–1101 (2004)
Y. Sun, W.J. Jusko, Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J. Pharm. Sci. 87, 732–737 (1998)
T. Teorell, Kinetics of distribution of substances administered to the body I. The extravascular modes of administration. Archs. Int. Pharmacodyn. Ther. 57, 205–225 (1937)
P.H. van der Graaf, J. Gabrielsson, Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development. Future Med. Chem. 1, 1371–1374 (2009)
J.G. Wagner, History of pharmacokinetics. Pharmacol. Ther. 12, 537–562 (1981)
G.B. West, J.H. Brown, The origin of allometric scaling laws in biology from genomes to ecosystems: Towards a quantitative unifying theory of biological structure and organization. J. Exp. Biol. 208, 1575–1592 (2005)
T.E. Wheldon, Mathematical Models in Cancer Research (Adam Hilger, Bristol/Philadelphia, 1988)
Acknowledgements
The present project is supported by the National Research Fund, Luxembourg, and cofunded under the Marie Curie Actions of the European Commission (FP7-COFUND). The authors like to thank Dr. Antje Walz and Dr. Thomas Wagner for their valuable comments and remarks.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Koch, G., Schropp, J. (2013). Mathematical Concepts in Pharmacokinetics and Pharmacodynamics with Application to Tumor Growth. In: Kloeden, P., Pötzsche, C. (eds) Nonautonomous Dynamical Systems in the Life Sciences. Lecture Notes in Mathematics(), vol 2102. Springer, Cham. https://doi.org/10.1007/978-3-319-03080-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-03080-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-03079-1
Online ISBN: 978-3-319-03080-7
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)
